AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS

AMGN 10.24.2024

Full Press ReleaseSEC FilingsOur AMGN Tweets

About Gravity Analytica

Recent News

  • 02.04.2025 - Q4 2024 Amgen Earnings Conference Call
  • 01.17.2025 - FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
  • 01.13.2025 - 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 12.06.2024 - 4 Statement of changes in beneficial ownership of securities

THOUSAND OAKS, Calif.,Oct. 24, 2024/PRNewswire/ --Amgen(NASDAQ:AMGN) today announced that it will report its third quarter 2024 financial results onWednesday, October 30, 2024, after the close of theU.S.financial markets. The announcement will be followed by a conference call with the investment community at4:30 p.m. ET. Participating in the call fromAmgenwill beRobert A. Bradway, chairman and chief executive officer, and other members ofAmgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments inAmgen's business given by management at certain investor and medical conferences, can be found onAmgen's website,www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted onAmgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About AmgenAmgendiscovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago,Amgenhelped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today.Amgenis advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024,Amgenwas named one of the "World's Most Innovative Companies" byFast Companyand one of "America's Best Large Employers" by Forbes, among otherexternal recognitions.Amgenis one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on theNasdaq Stock Marketbased on market capitalization.

For more information, visitAmgen.comand followAmgenonX,LinkedIn,Instagram,TikTok,YouTubeandThreads.

CONTACT:Amgen,Thousand OaksElissa Snook, 609-251-1407 (media)Justin Claeys, 805-313-9775 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2024-third-quarter-financial-results-302285159.html

SOURCEAmgen

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com